预测膳食植物甾醇干预无应答者的遗传基础:GenePredict-PS 双盲安慰剂对照随机两周期交叉研究方案
PS 期每日摄入 2.0 g PS(分两次,每次 1 g)。主要结局为低密度脂蛋白胆固醇(LDL-C)对 PS 的应答,并分析基因集变异与 PS 应答的关联,长期目标是开发预测 PS 应答的基因检测。
要点
- 携带特定 SNP 的受试者接受 PS 2.0 g/天或安慰剂各 4 周,交叉设计。
- 主要结局为 LDL-C 对 PS 干预的应答程度。
- 旨在评估基因集与 PS 应答关联能否用于预测无应答者。
核心结论
- 研究将探讨已识别的 SNP 与 LDL-C 对 PS 摄入应答的关联能否用于预测。
- 长期目标是开发基因检测以预测个体对膳食 PS 的应答。
研究设计与样本
- 双盲、安慰剂对照、随机两周期交叉试验。
- PS 期与安慰剂期各持续 4 周。
关键数值与推荐
- PS 期每日摄入 2.0 g PS,分两次、每次 1 g,随人造黄油单份摄入。
- 安慰剂为不含添加 PS 的相同人造黄油。
- 主要结局为 LDL-C 对 PS 受控给药的应答。
局限性
- 研究为方案阶段,尚未报告实际结果。
- 需前瞻性按基因型招募,实施具有复杂性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Functional food ingredients and natural health products have been demonstrated to reduce disease risk and thereby help to lower health care costs across populations at risk for chronic or degenerative diseases. However, typically a wide range of interindividual variability exists in response across individuals to nutritional and natural health product bioactives, such as plant sterols (PS). This study aims to determine and utilize information on the associations between genosets and the degree of responsiveness to dietary PS intervention, with a long-term objective of developing genetic tests to predict responses to PS. METHODS: This clinical trial is designed as a double-blind, placebo controlled, randomized two-period crossover study. Sixty-four eligible participants with the specific a priori-determined single nucleotide polymorphisms (SNPs) associated with a responsiveness to PS will consume PS or a placebo treatment for two 4-week periods. The PS treatment consists of two daily single portions of margarine, each providing 1 g PS during the PS period (2.0 g/day of PS in total). The placebo will be an identical margarine containing no added PS. Low-density lipoprotein cholesterol (LDL-C) responsiveness to the controlled administration of PS will be investigated as the primary outcome, and the associations between interindividual genoset variabilities and response to PS consumption will be determined. DISCUSSION: This research will provide further insight into whether the associations between previously identified SNPs and the response of LDL-C to PS consumption can be used in a predictive manner. It will also provide insight into the complexities of undertaking a nutrigenetic trial with prospective recruitment based on genotype. TRIAL REGISTRATION: ClinicalTrials.gov: Identifier: NCT02765516. Registered on 6 May 2016.
引用
- Shamloo M, Granger MJ, Trautwein EA, et al. Genetic basis for prediction of non-responders to dietary plant sterol intervention (GenePredict-PS): a study protocol for a double-blind, placebo-controlled, randomized two-period crossover study. Trials. 2020. PMID: 32487131. doi:10.1186/s13063-020-04364-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。